ID

17396

Descripción

Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC; ODM derived from: https://clinicaltrials.gov/show/NCT00786331

Link

https://clinicaltrials.gov/show/NCT00786331

Palabras clave

  1. 11/9/16 11/9/16 -
Subido en

11 de septiembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331

Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent
Descripción

written informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
histologically or cytologically confirmed non-small-cell lung cancer
Descripción

non-small-cell lung cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007131
unresectable stage iiib, stage iv and unresectable local relapse or metastatic disease, with evidence of disease progression after first line chemotherapy which should have included a platinum agent.
Descripción

metastatic disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027627
ecog performance status lower than or equal to 2
Descripción

ecog

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
adequate hematological, hepatic and renal functions
Descripción

hepatic and renal functions

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232805
UMLS CUI [2]
C0232741
life expectancy greater than or equal to 12 weeks
Descripción

life expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
prior treatment with only 1 chemotherapy regimen for the treatment of advanced disease which should have included a platinum agent
Descripción

chemotherapy regimen

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0392920
at baseline, presence of at least one measurable target lesion as per recist criteria
Descripción

measurable target lesion

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment with pemetrexed.
Descripción

pemetrexed

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0210657
patients who are pregnant or lactating
Descripción

pregnant or lactating

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
patients with any underlying medical condition that might be aggravated by treatment or which cannot be controlled.
Descripción

medical condition

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0012634
symptomatic brain metastases
Descripción

brain metastases

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0220650
history of another malignancy within the past five years except basal cell carcinoma of the skin or carcinoma in situ of the cervix.
Descripción

malignancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
concomitant treatment with any other anticancer drug.
Descripción

concomitant treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1707479

Similar models

Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
written informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
non-small-cell lung cancer
Item
histologically or cytologically confirmed non-small-cell lung cancer
boolean
C0007131 (UMLS CUI [1])
metastatic disease
Item
unresectable stage iiib, stage iv and unresectable local relapse or metastatic disease, with evidence of disease progression after first line chemotherapy which should have included a platinum agent.
boolean
C0027627 (UMLS CUI [1])
ecog
Item
ecog performance status lower than or equal to 2
boolean
C1520224 (UMLS CUI [1])
hepatic and renal functions
Item
adequate hematological, hepatic and renal functions
boolean
C0232805 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
life expectancy
Item
life expectancy greater than or equal to 12 weeks
boolean
C0023671 (UMLS CUI [1])
chemotherapy regimen
Item
prior treatment with only 1 chemotherapy regimen for the treatment of advanced disease which should have included a platinum agent
boolean
C0392920 (UMLS CUI [1])
measurable target lesion
Item
at baseline, presence of at least one measurable target lesion as per recist criteria
boolean
C1513041 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pemetrexed
Item
prior treatment with pemetrexed.
boolean
C0210657 (UMLS CUI [1])
pregnant or lactating
Item
patients who are pregnant or lactating
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
medical condition
Item
patients with any underlying medical condition that might be aggravated by treatment or which cannot be controlled.
boolean
C0012634 (UMLS CUI [1])
brain metastases
Item
symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1])
malignancy
Item
history of another malignancy within the past five years except basal cell carcinoma of the skin or carcinoma in situ of the cervix.
boolean
C0006826 (UMLS CUI [1])
concomitant treatment
Item
concomitant treatment with any other anticancer drug.
boolean
C1707479 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial